The fourth quarter of 2011 led the Diagnostics and Tools global market to an increase in equity returns and EBITDA multiples. The in-vitro diagnostics subsector had $445mm in announced private placements, making it the most active across the diagnostics and tools sector. The life science tools industry was the most active in terms of transaction volume on the M&A front, whereas in-vivo diagnostics had the highest announced transaction volume. Notable transactions for the period include a $54.1mm private placement in Sensors for Medicine and Science, Inc. and the $753mm acquisition of...
The Crosstree Capital Partners Pharma Outsourcing Aggregate Index jumped an astounding 14.7% during the first quarter of 2013. Private Placement and M&A activity was down for the quarter compared to the fourth quarter of 2012. The CDMO segment produced the greatest activity in the private placement and M&A markets, with 8 and 22 transactions respectively. Development showed strength in M&A with 21 total deals and the largest aggregate announced transaction value of any segment in M&A totaling $418 million. The region with the greatest activity in terms of volume in private...
